MORPHINE SULFATE
Total Payments
$1.2M
Transactions
26
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $692,101 | 14 | 0 |
| 2020 | $534,824 | 12 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.2M | 26 | 100.0% |
Top Doctors Receiving Payments for MORPHINE SULFATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Denver, CO | $1.2M | 26 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $1.2M
- UPSHER-SMITH LABORATORIES LLC $12.72
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 0
- Transactions 26
About MORPHINE SULFATE
MORPHINE SULFATE is a drug associated with $1.2M in payments to 0 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2020 to 2021. In 2021, $692,101 was paid across 14 transactions to 0 doctors.
The most common payment nature for MORPHINE SULFATE is "Consulting Fee" ($1.2M, 100.0% of total).